When to Use Skin Substitutes on Surgical Wounds
Skin substitutes should generally NOT be used routinely on surgical wounds, with the primary exception being post-surgical diabetic foot wounds where standard care has failed, and only when resources and expertise are available. 111
Primary Recommendations Based on Wound Type
Post-Surgical Diabetic Foot Wounds
- Consider negative pressure wound therapy (NPWT) as the preferred adjunctive treatment for post-surgical diabetes-related foot wounds 1
- Do NOT use cellular skin substitutes as routine adjunct therapy (conditional recommendation, low-quality evidence) 11
- Do NOT use acellular skin substitutes as routine adjunct therapy (conditional recommendation, low-quality evidence) 11
- Do NOT use autologous skin graft substitutes (strong recommendation against) 11
Key caveat: While some evidence suggests skin substitutes may improve healing rates, all studies had high risk of bias due to non-blinding, high dropout rates, and per-protocol analyses rather than intention-to-treat. The moderate costs and resources required make cost-effectiveness unlikely compared to standard care. 11
Deep Burns in Functional/Mobile Areas
Consider dermal substitutes in the acute phase (within 3-21 days of injury) for:
- Deep partial or full-thickness burns
- Functional anatomic areas: face, neck, axilla, elbow, popliteal regions
- Wounds >10 cm² requiring contracture prevention
Approach by depth:
- One-stage approach: Deep dermal to full-thickness wounds >10 cm² 2
- Two-stage approach: Same depth wounds with limited donor sites OR exposed bone/tendon 2
- Apply dermal substitute after surgical debridement
- Follow with autologous split-thickness skin graft after 14-21 days 3
Contraindications:
- Active wound infection 2
- Allergies to matrix components 2
- Electrical or chemical burns (use with extreme caution) 2
Non-Surgical Chronic Wounds
Do NOT use skin substitutes for non-surgical diabetic foot ulcers - insufficient evidence exists to support this practice 44
Alternative Treatments to Consider First
Before considering skin substitutes, optimize standard care:
For diabetic foot ulcers with inadequate healing after 2+ weeks:
For venous leg ulcers:
Critical Implementation Points
When skin substitutes ARE used:
- Secure with suture, adhesive strips, and/or secondary dressing 11
- Requires specialized expertise and organization 4
- Monitor for adverse effects: wound maceration, dressing retention, infection 44
- Expect stimulation of healing process but NOT complete epithelialization 4
Common pitfall: The evidence base is plagued by heterogeneous products, inconsistent blinding, high dropout rates, and publication bias. Do not assume all skin substitutes are equivalent or effective. 11
Bottom Line Algorithm
- Is this a post-surgical diabetic foot wound? → Try NPWT first 1
- Is this an acute deep burn in a functional area? → Consider dermal substitute if >10 cm² 23
- Is this any other surgical wound? → Use standard wound care; skin substitutes not recommended 11
- Has standard care failed for 2+ weeks? → Consider specific alternatives (sucrose-octasulfate, autologous platelet products, placental products) before skin substitutes 11
The overarching principle: skin substitutes are expensive, require expertise, and lack robust evidence for routine use in most surgical wounds. Standard wound care with appropriate debridement, infection control, and offloading remains the foundation of treatment.